Ipamorelin is a selective growth hormone secretagogue studied for its targeted interaction with ghrelin receptors and its influence on GH release. Research frequently examines its endocrine signalling effects, appetite-modulation pathways, and GH-related metabolic outcomes.
Each research pack contains sterile, lyophilised Ipamorelin vials produced for consistency and accuracy in scientific environments. This peptide is intended strictly for laboratory use and must not be applied clinically.
Available Variants:
• 2mg × 10 vials
• 5mg × 10 vials
• 10mg × 10 vials
